A Groundbreaking Stand-Alone Diagnostic Kit to Predict Human Papilloma Virus Infections Evolving into Cervical Cancer

Project Information

HPV OncoPredict

Grant agreement ID: 806551

DOI 10.3030/806551

Project closed

EC signature date 22 August 2018

Start date 1 September 2018

End date 30 April 2022

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 2 945 000,00

EU contribution € 2 923 061,00

Coordinated by

GENEFIRST LIMITED
United Kingdom

Deliverables

Open Research Data Pilot (1)

Access to Scientific Publications

GeneFirst and Hiantis agree to have open access to both publications and research data in compliance with EU Open Data Access rules

Websites, patent fillings, videos etc. (1)

Social Media and Community Platform Website

GeneFirst and Hiantis to work together in developing social media strategy

Publications

Peer reviewed articles (1)

VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples

Author(s): M. Arbyn, E. Peeters, I. Benoy, D. Vanden Broeck, J. Bogers, P. De Sutter, G. Donders, W. Tjalma, S. Weyers, K. Cuschieri, M. Poljak, J. Bonde, C. Cocuzza, F.H. Zhao, S. Van Keer, A. Vorsters
Published in: Journal of Clinical Virology, Issue 107, 2018, Page(s) 52-56, ISSN 1386-6532
Publisher: Elsevier BV
DOI: 10.1016/j.jcv.2018.08.006

Other (1)

Human papillomavirus (HPV) detection in vaginal self-samples: evaluation of eNat® as an alternative suspension medium to ThinPrep®PreservCyt® for vaginal swabs

Author(s): Chiara Giubbi, Marianna Martinelli, Ivan Vallini, Silvia Paganoni, Tarig Dafa'alla, Federica Perdoni, Rosario Musumeci, Winnie Wu, Santina Castriciano, Paolo Romano, Clementina E. Cocuzza
Published in: Open Research Europe, 2021
Publisher: Horizon 2020
DOI: 10.12688/openreseurope.14344.2